| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.463 | 61.770 | 47.620 | 33.045 | 31.363 | 20.667 | 31.659 | 21.065 | 8.179 | 0 |
| Total Income - EUR | 45.510 | 61.775 | 47.838 | 33.045 | 31.363 | 20.667 | 31.659 | 21.065 | 8.179 | 0 |
| Total Expenses - EUR | 39.611 | 44.295 | 35.108 | 24.212 | 20.184 | 15.313 | 17.058 | 19.901 | 19.460 | 2.899 |
| Gross Profit/Loss - EUR | 5.899 | 17.480 | 12.730 | 8.833 | 11.180 | 5.354 | 14.601 | 1.165 | -11.281 | -2.899 |
| Net Profit/Loss - EUR | 4.533 | 16.862 | 12.252 | 8.502 | 10.866 | 5.163 | 14.284 | 958 | -11.363 | -2.899 |
| Employees | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 1 |
Check the financial reports for the company - Med Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.791 | 1.385 | 0 | 0 | 0 | 0 | 0 | 1.612 | 1.391 | 1.167 |
| Current Assets | 4.338 | 22.043 | 13.616 | 12.984 | 15.250 | 9.414 | 18.262 | 5.703 | 1.798 | 2.792 |
| Inventories | 178 | 485 | 0 | 621 | 930 | 523 | 774 | 621 | 1.198 | 1.191 |
| Receivables | 856 | 714 | 489 | 1.385 | 1.575 | 1.497 | 1.464 | 1.345 | 177 | 592 |
| Cash | 3.304 | 20.843 | 13.126 | 10.979 | 12.745 | 7.394 | 16.024 | 3.738 | 423 | 1.009 |
| Shareholders Funds | -2.498 | 14.389 | 12.519 | 8.675 | 11.036 | 5.329 | 14.447 | 1.121 | -11.200 | -14.037 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 11.627 | 9.039 | 1.096 | 4.328 | 4.336 | 4.216 | 4.050 | 6.332 | 14.567 | 18.177 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Med Plus Srl